Publications by authors named "Philippa Hand"
Article Synopsis
- People with neuroendocrine neoplasms (NENs) encounter significant challenges such as delayed diagnosis and lack of awareness among healthcare providers, leading to limited access to proper care.
- A new patient care pathway was developed in England to improve disease management for NEN patients, incorporating feedback from literature reviews and expert interviews.
- This pathway aims to identify and address care barriers, promoting equitable treatment across the UK, and is designed to integrate into existing multidisciplinary teams within the NHS.
In the Original Article, there is an error in the "participants" section of Results. The correct sentence is "A total of 213 participants took part in the studies, including 34 patients with acromegaly and 28 patients with NETs".
View Article and Find Full Text PDFIntroduction: Although the previous lanreotide autogel/depot syringe had been well received, feedback indicated that improvements could be made to make it more user-friendly. Additionally, the view that patients should have greater involvement in the research and development process is echoed by the International Neuroendocrine Cancer Alliance. A series of studies aimed to develop and validate a new syringe that works better for patients, caregivers and healthcare professionals (HCPs) by involving these groups at key stages in the development and testing process.
View Article and Find Full Text PDF